March 10th, 2013
Fibrinolysis May Benefit Late-Arriving STEMI Patients
Larry Husten, PHD
For more of our ACC.13 coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting, check out our Coverage Headquarters. Although primary PCI has emerged as the best treatment for STEMI, most patients don’t receive this treatment within […]
March 10th, 2013
ACC.13: Is Cangrelor an Antiplatelet CHAMPION?
Deepak L. Bhatt, MD, MPH, Richard A. Lange, MD, MBA and L. David Hillis, MD
Deepak Bhatt sheds light on findings from the CHAMPION PHOENIX trial and their implications for clinical practice.
March 10th, 2013
Cangrelor During PCI May Reduce Ischemic Events
Larry Husten, PHD
For more of our ACC.13 coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting, check out our Coverage Headquarters. In the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) trial, the intravenous […]
March 10th, 2013
Learning to Network: Blogging from ACC.13
Jeremiah Depta, MD
At prior ACC meetings, I had not made such a concerted effort to speak with the luminaries in our field and, unfortunately, this was a monumental mistake.
March 10th, 2013
You Are My Sunshine: Blogging from ACC.13
Sandeep Mangalmurti, MD, JD
“It is difficult to get a man to understand something, when his salary depends upon his not understanding it.”
March 10th, 2013
The Real Question About Reducing Hospital Readmissions: Blogging from ACC.13
Kumar Dharmarajan, MD MBA
How do we best align our inpatient assessments with patients’ real stresses and challenges after hospital discharge?
March 10th, 2013
Thinking about What Comes After Fellowship: Blogging from ACC.13
Megan Coylewright, MD MPH
Several Cardiology Fellows who are attending ACC.13 in San Francisco this week are blogging for CardioExchange. The Fellows include Tariq Ahmad, Megan Coylewright, Jeremiah Depta, Kumar Dharmarajan, Payal Kohli, and Sandeep Mangalmurti. View the previous post here and the next one here. In the current market, it is challenging to know how best to proceed once it is time for the next big transition…finding […]
March 10th, 2013
Great Venue, Great Sessions, but Disappointments Too: Blogging from ACC.13
Tariq Ahmad, MD, MPH
Disappointments as the PREVAIL presentation is pulled and the author is shut out of crowded sessions
March 9th, 2013
ACC.13 Headquarters
CardioExchange Editors, Staff
CardioExchange is dedicated to bringing you the latest from ACC.13. Check out our coverage below ─ and some of the great debates these posts have sparked ─ then tell us what you think! News: Following an Embargo Break PREVAIL Trial Won’t be Presented at ACC HPS2-THRIVE: A ‘Disappointing But Clear’ Result Cangrelor During PCI May […]
March 9th, 2013
HPS2-THRIVE: A ‘Disappointing But Clear’ Result
Larry Husten, PHD
For more of our ACC.13 coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting, check out our Coverage Headquarters. The results of HPS2-THRIVE were “disappointing but clear,” said Jane Armitage, who presented the results this morning at the […]